Reports - Point of Care Diagnostics Market
HealthcarePoint of Care Diagnostics Market
Point of Care Diagnostics Market Size, Growth Projections And Insights 2025-2035 by Product (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology) by End Users (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Global Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. Global Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
5. Global Point of Care Diagnostics Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. North America Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. North America Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
Chapter 5 Europe Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Europe Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. Europe Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
Chapter 6 Asia Pacific Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. Asia Pacific Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
Chapter 7 Latin America Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. Latin America Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
Chapter 8 Middle East & Africa Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Point of Care Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Point of Care Diagnostics Market - by Product
3.1. By Glucose Testing
3.2. By Hb1Ac Testing
3.3. By Coagulation Testing
3.4. By Fertility/Pregnancy
3.5. By Infectious Disease
3.6. By Cardiac Markers
3.7. By Thyroid Stimulating Hormone
3.8. By Hematology
3.9. By Primary Care Systems
3.10. By Decentralized Clinical Chemistry
3.11. By Feces
3.12. By Lipid Testing
3.13. By Cancer Marker
3.14. By Blood Gas/Electrolytes
3.15. By Ambulatory Chemistry
3.16. By Drug of Abuse (DOA) Testing
3.17. By Urinalysis/Nephrology
4. Middle East & Africa Point of Care Diagnostics Market - by End Users
4.1. By Clinics
4.2. By Hospitals
4.3. By Home
4.4. By Assisted Living Healthcare Facilities
4.5. By Laboratories
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. F. Hoffmann-La Roche Ltd.
2. Qiagen
3. Danaher Corp.
4. Becton Dickinson (BD)
5. Biomerieux SA
6. Abbott Laboratories
7. Siemens Healthcare AG
8. Zoetis Inc.
9. Instrumentation Laboratory
10. Nova Biomedical
11. Trividia Health Inc.
12. Quidel Corp.
13. Trinity Biotech
14. Sekisui Diagnostics
15. Orasure Technologies Inc.
16. Nipro Corp.
17. Spectral Medical Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By